Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
7T FACES: Effects of Citalopram on Brain Response to Faces
NCT06412315Recruiting
- Sponsor
- University of Oxford
- Start
- Feb 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Citalopram with Placebo (2 arms). Primary endpoints: fMRI BOLD univariate analysis at 3 hours and fMRI BOLD multivariate analysis at 3 hours. Started Feb 2025; status: recruiting.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06412315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06412315.